AzTrials
AzTrials

MyopiaSMART2NCT05030103

Myopia Prevention With Reading Glasses

A study testing Reading glasses, +2.0 diopters in people with Myopia, run by Reis Augenklinik AG at 1 site in Liechtenstein.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The last decades have seen a significant increase in myopia in children and young adults. Possible cause: increased near-work (school, computer, smartphone). Rationale: Reading glasses support the accommodative effort of the eyes. Read more about this study

Who is it for?
Ages 6 to 25 yearsHealthy volunteers can take part
Conditions the study is for
Myopia
What is being tested?
Reading glasses, +2.0 diopters
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,500 participants
Where
1 siteLiechtenstein
Study dates
1 Oct 2023to 31 Dec 2031
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Children of both sexes from the age of 6
  • Children whose parents have read and signed the declaration of consent
  • Spherical equivalent of refraction <-0.5 dpt.
  • Distant vision in both eyes without correction 1.0
  • Willingness to wear reading glasses
  • Possibility of a five-year follow-up

Who cannot join

  • Children who already wear glasses
  • Astigmatism over 1.5 diopters
  • Anisometropy greater than 1.5 diopters
  • Eye diseases that affect refraction development

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Alexander Reis, Prof. Dr. contact

+4233990424

info@augenklinik.li

Amir Nassri, Dr. med. contact

+4233990424

info@augenklinik.li

Liechtenstein1 site
  • Reis Augenklinik AG

    Bendern, 9487

    Alexander Reis, Prof. Dr., +4233990424, info@augenklinik.li

    Amir Nassri, Dr. med., +4233990424, info@augenklinik.li

About this study

Official title: An Open, Prospective Clinical Trial on the Use of Reading Glasses in Children to Prevent Myopia

The last decades have seen a significant increase in myopia in children and young adults. Possible cause: increased near-work (school, computer, smartphone). Rationale: Reading glasses support the accommodative effort of the eyes. By wearing reading glasses, there is less interference with the young eye´s physiological axial growth despite increased near-work. Main objective: does the use of reading glasses during near-work in children and adolescents reduce the incidence of myopia.

Read the detailed description

In myopia (nearsightedness), the eyeball is relatively to long, which means that the image produced by the cornea and lens is displayed in front of the retina.

The axial length of an adult eye is on average around 23 millimeters. Every millimeter of additional length must be corrected with a -2.75 diopter lens.

In newborns, the eyeball is about 18 millimeters long. It is believed that there are feedback loops during childhood and adolescence to control the growth of the eye.

Epidemiological studies show that myopia is an increasing health problem. There is a growing body of epidemiological evidence that environmental factors can influence the development of myopia.

The link between the environment and myopia lies in the quality of the retinal image. Experimental studies in various species have shown that if the retinal image is missing, eye growth is disturbed. Of even greater importance for the development of myopia is the knowledge that the primate eye can change its growth, depending on the strength and type of blurring of the retinal image: if lenses are placed in front of the eye during development, the eye growth changes in such a way that a sharp retinal image is achieved through these lenses. If divergent lenses are placed in front of the eye, the eye becomes longer, and if convergent lenses are placed in front of it, it becomes correspondingly shorter.

So myopia is the result of a failure in these emmetropization mechanisms. The positive correlation of myopia with a higher level of education suggests that increased close work interferes with emmetropization. The growth in length of the eye changes in such a way that it adapts to this requirement: the eye adjusts itself to the close work: it becomes myopic.

Myopia is thus possibly a physiological adaptation to increased near work with the aim of improving the quality of the retinal image during close work. However, this can only be achieved at the expense of the image quality when looking into the distance.

The investigators submitted a study on this subject to the Cantonal Ethics Committee of the Canton of Zurich in 2003:

"An open, prospective, randomized study on the use of reading glasses in children with normal vision to prevent myopia" Unique Protocol ID: FR-2005-01-01 Approval Status: Approved Approval Number: KEK-StV-Nr. 19/03

This was and is so far the only clinical study that examined the effect of reading glasses on the development of myopia in emmetropic (normally sighted) children and has led to Patent No: US 8,511,819 B2, Aug. 20, 2013 "Prevention of myopia acquisition in children and young adults using reading glasses"

Conditions
Myopia
Being tested
Reading glasses, +2.0 diopters
Keywords
Children, prevention
Medical subject headings
Myopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Reading glasses, +2.0 dioptersDevice

    The participants in the glasses-group are asked to wear the reading glasses during near-work.

Study groups in NCT05030103
Study groupRoleWhat they receive
GlassesActive comparatorThe participants are asked to wear reading glasses during near-work. The reading glasses have a lenspower of +2.0 diopters.
Receives: Device: Reading glasses, +2.0 diopters
ControlNo interventionAge matched children and adolescents, no intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Development of myopia

    Number of participants which develop myopia within the follow-up period of five years

    Measured: Five years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Sep 2021
  2. Study start1 Oct 2023 (estimated)
  3. Primary completion30 Sep 2031 (estimated)
  4. Study completion31 Dec 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Open, propensity score method
Masking
None (open label)
Enrolment
1,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05030103
Sponsor's protocol ID
SMART2
Acronym
SMART2
Status last verified
Feb 2023
First submitted
30 Aug 2021
Last updated
23 Feb 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Reading glasses, +2.0 diopters in people with Myopia, run by Reis Augenklinik AG at 1 site in Liechtenstein.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Liechtenstein. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Alexander Reis, Prof. Dr. (+4233990424, info@augenklinik.li), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Development of myopia (time frame: Five years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in